全部
(>90% nanotubes)
(99.7%-Sn)
>85%
>90%
>95%
>95% (SDS-PAGE), recombinant, expressed in E. coli overproducing strain, lyophil
>96%
>97%
>97% (>99% ee)
>97% (HPLC), solid
>98%
~0.1 mg/mL, recombinant, expressed in E. coli, buffered aqueous solution
~0.6 M in DMF
~95%
≥85% (HPLC)
≥90.0% (HPLC)
≥90%
≥90% (HPLC)
≥90% (HPLC), powder
≥92.5%
≥95.0% (HPLC)
≥95%
≥95% (HPLC)
≥95% (HPLC), powder
≥95% (HPLC), solid
≥95% (LC/MS-ELSD)
≥95%, solid
≥96%
≥97.0% (GC)
≥97%
≥97% (HPLC)
≥97% (HPLC), lyophilized powder
≥97% (HPLC), powder
≥97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, suitable
≥98.0% (HPLC)
≥98.0% (HPLC), 98.0-102.0 wt. % (AT)
≥98%
≥98% (elemental analysis)
≥98% (HPLC)
≥98% (HPLC), solid
≥98% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, suitable
≥98% (TLC)
≥99.0% (HPLC)
≥99.0% (sum of enantiomers, HPLC)
≥99% (HPLC), solid
≥99% (titration), crystalline
≥99% (TLC)
0
0.5 mg/mL in Methanol
0.95
1 mg/mL in DMSO
10 mM in H2O
10 μm
10.0 μg/mL in Isooctane
100 μg/mL
100 μg/mL in MeOH
100 μg/mL in Methanol
100 μg/mL in PT Methanol
100-200?mesh, extent of labeling: 1.4-2.2?mmol/g N loading, 1?% cross-linked wit
100.00%
100%
1000 μg/mL
1000 μg/mL in Acetonitrile
1000μg/mL
100μg/mL
100μgbase/mL
2 μg/mL in Methanol
2% cross-linked, 30-60 mesh
2% cross-linked, ca 60 mesh, 8.0meq/g
20.0 mg/mL in CH2Cl2
20.0 mg/mL in MeOH
200μg/mL
28-30% methoxyl, 7-12% hydroxypropyl
3000μg/mL
37% w/w aq.
40%
5?wt. % in methanol
500μg/mL
50μg/mL
595ug/mg
60 well MicroWell? MiniTray for serological applications, non-treated, polystyre
60 μg/g in Anisole
60 μg/mL in MtBE
60-100nm
60-64%
60%
60+%
60+% n-hexane
60nm
60μm
65%
7-8% in methanol
70.0%(N)
70%
70% C{60}, 28% C{70}
72 well MicroWell? MiniTray for serological applications, non-treated, polystyre
722-764μg/mg
75.0%(GC)
75%
77% C{60}, 22% C{70}, <2% higher
77% C{60}H{x}, 22% C{70}H{y}
7μm
80%
81.0%
832-970ug/mg
85.0%
85.0%(LC)
85.0%(LC&QNMR)
85%
88.0%
88.0%(GC)
89%
90.0%
90.0%(GC)
90.0%(LC)
90.0%(LC&N)
90.0%(T)
90.40%
90%
90+%
92.0%
92.0%(T)
92%
93.0%(T)
93.50%
93%
94.0%
94%
94% HPLC
95
95-102%
95.0%
95.0%(GC)
95.0%(GC&T)
95.0%(LC)
95.0%(LC&QNMR)
95.0%(LC&T)
95.0%(QNMR)
95.0%(T)
95%
95% (99% ee)
95% (contains 30-35%Pinacone)
95% (stabilized with MEHQ)
95% HPLC
95% min
95% mix TBC as stabilizer
95%, (99% ee)
95%+
95%mixTBCasstabilizer
95+%
957.2ug/mg
96.0%
96.0%(GC)
96.0%(LC)
96.0%(LC&N)
96.0%(LC&T)
96%
96% (HPLC)
97
97-103%(T),beta≥60%(HPLC)
97.0%
97.0%(GC)
97.0%(GC&T)
97.0%(LC)
97.0%(LC&T)
97.0%(T)
97.5%
97.60%
97.70%
97%
97% HPLC
97% mix TBC as stabilizer
97%,stabilized with HQ
97%mixTBCasstabilizer
97+%
97+% (>99% ee)
98.0%
98.0%(GC)
98.0%(GC&N)
98.0%(GC&T)
98.0%(LC)
98.0%(LC&N)
98.0%(LC&QNMR)
98.0%(LC&T)
98.0%(N)
98.0%(N&T)
98.0%(T)
98.0%(T&LC)
98.00%
98.5%
98.50%
98%
98% (stabilized with MEHQ)
98% (99% ee)
98% (contains 6-10%HOAc)
98% (HPLC)
98% (stabilized with MEHQ)
98% +(stabilized with MEHQ)
98% 98%atom%D
98% 99%ee
98% GC,T
98% HPLC
98% HPLC,N
98% HPLC,T
98% mix TBC as stabilizer
98% T
98%, (99% ee)
98%+
98+%
99.0%
99.0%(GC)
99.0%(GC&T)
99.0%(LC)
99.49%
99.5%
99.5%(GC&T)
99.5%(LC)
99.50%
99.6%
99.70%
99.8%
99.9%
99.9+%
99.95%
99.98%
99.99%
99.99+%
99.999%
99%
99%
99% HPLC
99+%
Acid Value 156-182
affinity isolated antibody, buffered aqueous solution
affinity isolated antibody, lyophilized powder
AldrichCPR
aminopeptidase substrate
approximately 70% : 30%
Avanti Polar Lipids
BioReagent, for fluorescence
BioReagent, suitable for fluorescence
BioReagent, suitable for fluorescence, ~90% (HPLC)
BioReagent, suitable for fluorescence, ≥80% (HPLC)
BioReagent, suitable for fluorescence, ≥85% (HPCE)
BioReagent, suitable for fluorescence, ≥85% (HPLC)
BioReagent, suitable for fluorescence, ≥90% (HPCE)
BioReagent, suitable for fluorescence, ≥90% (HPLC)
BioReagent, suitable for fluorescence, ≥90% (T)
BioReagent, suitable for fluorescence, ≥95% (HPCE)
BioReagent, suitable for fluorescence, ≥95% (HPLC)
BioReagent, suitable for fluorescence, ≥95% (TLC)
BioReagent, suitable for fluorescence, ≥96.0% (HPLC)
BioReagent, suitable for fluorescence, ≥97.0% (HPLC)
BioReagent, suitable for fluorescence, ≥98.0% (HPCE)
BioReagent, suitable for fluorescence, ≥98.0% (HPLC)
BioReagent, suitable for fluorescence, ≥98.0% (T)
BS
calpain substrate
cathepsin H substrate
certified reference material, 1000 μg/mL each component in isooctane
Chromophore for substrates
clone 11E4, purified immunoglobulin, buffered aqueous solution
clone HDAC7-97, purified from hybridoma cell culture
clone LDS-68, ascites fluid
clone LK1, ascites fluid
clone LK2, ascites fluid
contains acid of crystalization
dipeptidylpeptidase IV substrate
elastase substrate
fluorescent amino acid
IgG fraction of antiserum
IgG fraction of antiserum, buffered aqueous solution
Leucine aminopeptidase substrate
Loss on drying≤10%
min. 85%
min. 95%
min. 97%
min. 98%
min. 98% (>99% ee)
N/A
neat
nonionic detergent
Odorant used in allergy studies
P{2}O{7} 43.5-48.5%
pH 7 in Water
phase 5% Carbowax 20M, matrix 40/60 Chromosorb T support, bottle of 50?g
phase none, matrix 60/80 Molecular Sieve 5A support, L × O.D. × I.D. 6.0?ft (1.8
phase Si-60, 5?μm particle size, L × I.D. 25?cm × 4.6?mm
pkg of 25 sheets, sheet L × W 20 cm × 20 cm, aluminum support
pkg of 50 plates, plate L × W 20 cm × 10 cm, glass support
powder
PRECISIO? Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70%
protease substrate
protein C substrate
recombinant, expressed in baculovirus infected Sf9 cells (truncated human sequen
Sample P12
solid
solution (supplied in DMSO)
sublimed, 99.9%
suitable for fluorescence
suitable for fluorescence, ≥95.0% (coupling assay to aminopropyl silica gel)
suitable for fluorescence, ≥98.0% (TLC)
suitable for use as an indicator in chloride titration, ~90% (TLC), powder
top I.D. 122?mm
top I.D. 147?mm
Varied conc. by volume
Varied conc. in 2-5% Nitric Acid
Varied conc. in 2-5% Nitric Acid, tr Hydrofluoric acid
Varied conc. in Isooctane
Varied conc. in Water
W,F,F (specially cleaned) separators, O.D. × L 6?mm × 75?mm, pkg of 50?ea
W,W,W separators, O.D. × L 8 mm × 100 mm, pkg of 50 ea